Merck MRK, known as MSD outside the United States and Canada,
today announced that its board of directors has authorized additional
purchases of up to $15 billion of Merck's common stock for its treasury.
The company expects to repurchase approximately $7.5 billion of common
stock over the next 12 months, financed through a combination of debt
issuance and operating cash flows, with the remainder to be repurchased
over time with no time limit. Purchases may be made in open-market
transactions, block transactions on or off an exchange, or in privately
negotiated transactions.
“This share repurchase program, combined with our strong dividend,
reinforces our continued commitment to delivering increased value to
shareholders,” said Kenneth
See full press release
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in